Literature DB >> 1000504

The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture.

M Lippman, G Bolan, K Huff.   

Abstract

We have established or characterized six lines of human breast cancer maintained in long-term tissue culture for at least 1 year and have examined these lines for estrogen responsiveness. One of these cell lines, MCF-7, shows marked stimulation of macromolecular synthesis and cell division with physiological concentrations of estradiol. Antiestrogens are strongly inhibitory, and at concentrations greater than 3 X 10(-7) M they kill cells. Antiestrogen effects are prevented by simultaneous treatment with estradiol or reversed by addition of estradiol to cells incubated in antiestrogen. Responsive cell lines contain high-affinity specific estradiol receptors. Antiestrogens compete with estradiol for these receptors but have a lower apparent affinity for the receptor than estrogens. Stimulation of cells by estrogens is biphasic, with inhibition and cell death at concentrations of 17beta-estradiol or diethylstilbestrol exceeding 10(-7) M. Killing by high concentrations of estrogen is probably a nonspecific effect in that we observe this response with 17alpha-estradiol at equivalent concentrations and in the otherwise unresponsive cells that contain no estrogen receptor sites.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1000504

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  133 in total

1.  Estrogen mitogenic action. III. is phenol red a "red herring"?

Authors:  J E Moreno-Cuevas; D A Sirbasku
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000 Jul-Aug       Impact factor: 2.416

2.  Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women.

Authors:  B M Sherman; F K Chapler; K Crickard; D Wycoff
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

3.  Down-regulation of androgen receptor by progestins and interference with estrogenic or androgenic stimulation of mammary carcinoma cell growth.

Authors:  R Hackenberg; J Hofmann; G Wolff; F Hölzel; K D Schulz
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

Review 4.  Molecular basis for therapy resistance.

Authors:  Per E Lønning
Journal:  Mol Oncol       Date:  2010-04-24       Impact factor: 6.603

5.  Endocrine Treatment - 'Old-Fashioned' Therapy Becoming Redundant in an Era of Molecular Medicine?

Authors:  Per Eystein Lønning
Journal:  Breast Care (Basel)       Date:  2008-12-02       Impact factor: 2.860

6.  Biological differences among MCF-7 human breast cancer cell lines from different laboratories.

Authors:  C K Osborne; K Hobbs; J M Trent
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

7.  Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells.

Authors:  R R Perry; Y Kang; B Greaves
Journal:  Ann Surg Oncol       Date:  1995-05       Impact factor: 5.344

8.  Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression.

Authors:  E A Musgrove; J A Hamilton; C S Lee; K J Sweeney; C K Watts; R L Sutherland
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

9.  Two new estrogen-supersensitive variants of the MCF-7 human breast cancer cell line.

Authors:  C Natoli; G Sica; V Natoli; A Serra; S Iacobelli
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

10.  Physicochemical and genetic evidence for specific antiestrogen binding sites.

Authors:  J C Faye; S Jozan; G Redeuilh; E E Baulieu; F Bayard
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.